Cargando…

“Late” Withdrawal Syndrome after Carbamazepine In Utero Exposure in a CYP2C9 Slow Metabolizer Newborn

We report a case of carbamazepine withdrawal syndrome following in utero exposure to carbamazepine related to a pharmacogenetic predisposition factor. The infant was born at 37 1/7 weeks’ gestation by cesarean section to a mother treated for epilepsy with carbamazepine. One hour and thirty minutes a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Passia, Evangelia, Rock, Nathalie, Pfister, Riccardo E., Ing Lorenzini, Kuntheavy R., Desmeules, Jules, Samer, Caroline F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399605/ https://www.ncbi.nlm.nih.gov/pubmed/28484392 http://dx.doi.org/10.3389/fphar.2017.00217

Ejemplares similares

CYP450 Genotype—Phenotype Concordance Using the Geneva Micrococktail in a Clinical Setting
por: Ing Lorenzini, Kuntheavy, et al.
Publicado: (2021)

Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic Defect
por: Ing Lorenzini, Kuntheavy, et al.
Publicado: (2016)

Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activity
por: Bouatou, Yassine, et al.
Publicado: (2014)

Practice of CYP450 genotyping and phenotyping in children in a real-life setting
por: Rodieux, Frédérique, et al.
Publicado: (2023)

Applications of CYP450 Testing in the Clinical Setting
por: Samer, C. F., et al.
Publicado: (2013)

Opioid‐related adverse drug reactions in patients visiting the emergency division of a tertiary hospital
por: Ing Lorenzini, Kuntheavy, et al.
Publicado: (2022)

Evaluation of Phenotypic and Genotypic Variations of Drug Metabolising Enzymes and Transporters in Chronic Pain Patients Facing Adverse Drug Reactions or Non-Response to Analgesics: A Retrospective Study
por: Rollason, Victoria, et al.
Publicado: (2020)

Dexamethasone exposure in normal‐weight and obese hospitalized COVID‐19 patients: An observational exploratory trial
por: Abouir, Kenza, et al.
Publicado: (2022)

Case Report: Opioid Use Disorder Associated With Low/Moderate Dose of Loperamide in an Intellectual Disability Patient With CYP3A and P-Glycoprotein Reduced Activity
por: Guinchat, Vincent, et al.
Publicado: (2022)

Interaction between Fexofenadine and CYP Phenotyping Probe Drugs in Geneva Cocktail
por: Bosilkovska, Marija, et al.
Publicado: (2019)

Transient Splenial Lesion Following Abrupt Withdrawal of Carbamazepine
por: Fuseya, Yasuhiro, et al.
Publicado: (2017)

A severe case of rhabdomyolysis after Moderna mRNA anti‐COVID‐19 vaccine with a literature review
por: Sheka, Maria, et al.
Publicado: (2023)

Evaluation of CYP1A2 activity: Relationship between the endogenous urinary 6‐hydroxymelatonin to melatonin ratio and paraxanthine to caffeine ratio in dried blood spots
por: Magliocco, Gaëlle, et al.
Publicado: (2022)

MD Investigation on the Interaction between Carbamazepine and Two CYP Isoforms, CYP3A4 and CYP3A5
por: Liu, Shuhui, et al.
Publicado: (2023)

Postnatal onset of severe growth retardation after in utero exposure to carbamazepine and phenobarbital: a case report
por: Liguori, Alice, et al.
Publicado: (2009)

Physiologically‐Based Pharmacokinetic Modeling for the Prediction of CYP2D6‐Mediated Gene–Drug–Drug Interactions
por: Storelli, Flavia, et al.
Publicado: (2019)

Evaluation of Pupillometry for CYP2D6 Phenotyping in Children Treated with Tramadol
por: Rodieux, Frédérique, et al.
Publicado: (2023)

Reversible ventricular arrythmia induced by dasatinib
por: Spechbach, Hervé, et al.
Publicado: (2013)

Pharmacogenetics of CYP3A5 on Carbamazepine pharmacokinetics in epileptic patients developing toxicity
por: Al-Gahtany, Mubarak, et al.
Publicado: (2014)

Pharmacovigilance analysis of the Vigibase on neonatal withdrawal syndrome following in utero exposure to antidepressants
por: Gastaldon, C., et al.
Publicado: (2023)

Atypical femoral fracture following bisphosphonate treatment in a woman with osteogenesis imperfecta—a case report
por: Meier, Raphael P H, et al.
Publicado: (2012)

DNA methylation patterns in newborns exposed to tobacco in utero
por: Ivorra, Carmen, et al.
Publicado: (2015)

Prediction of Metabolic Interactions With Oxycodone via CYP2D6 and CYP3A Inhibition Using a Physiologically Based Pharmacokinetic Model
por: Marsousi, N, et al.
Publicado: (2014)

Effects of EPHX1 and CYP3A4 polymorphisms on carbamazepine metabolism in epileptic patients
por: Caruso, Antonietta, et al.
Publicado: (2014)

The influence of CYP2C8*3 on carbamazepine serum concentration in epileptic pediatric patients
por: Milovanovic, DD, et al.
Publicado: (2016)

Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting
por: Lenoir, Camille, et al.
Publicado: (2022)

Stressful Newborn Memories: Pre-Conceptual, In Utero, and Postnatal Events
por: Papadopoulou, Zoe, et al.
Publicado: (2019)

Markedly Elevated Carbamazepine-10,11-epoxide/Carbamazepine Ratio in a Fatal Carbamazepine Ingestion
por: Russell, Jason L., et al.
Publicado: (2015)

Polymorfism Of CYP2C9 And 3A5 and carbamazepine hypersensitivity reactions in Brazilian subjects
por: Tanno, Luciana, et al.
Publicado: (2014)

Polymorfism Of CYP2C9 And 3A5 and carbamazepine hypersensitivity reactions in Brazilian subjects
por: Tanno, Luciana, et al.
Publicado: (2014)

The 1β-Hydroxy-Deoxycholic Acid to Deoxycholic Acid Urinary Metabolic Ratio: Toward a Phenotyping of CYP3A Using an Endogenous Marker?
por: Magliocco, Gaëlle, et al.
Publicado: (2021)

Immune function in newborns with in-utero exposure to anti-TNFα therapy
por: Weiss, Batia, et al.
Publicado: (2022)

Non-Recurrence of Carbamazepine Induced Vitiligo after Rechallenge with Carbamazepine
por: Saeedloo, Masoomeh, et al.
Publicado: (2013)

Fentanyl: Fetal bladder atony following in-utero exposure; neonatal opioid withdrawal syndrome: case report
Publicado: (2021)

In Utero Exposure to Dioxins and Dioxin-like Compounds and Anogenital Distance in Newborns and Infants
por: Vafeiadi, Marina, et al.
Publicado: (2012)

Personalizing carbamazepine therapy
por: Mushiroda, Taisei, et al.
Publicado: (2011)

Membranous nephropathy and carbamazepine
por: Sangeetha, B., et al.
Publicado: (2014)

Carbamazepine and Hematological Malignancies
por: Yavaşoğlu, İrfan, et al.
Publicado: (2013)

Carbamazepine-induced angioedema
por: Subramanian, Ansha, et al.
Publicado: (2016)

Acute Carbamazepine Intoxication
por: Gallego, María Dolores Calabria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_puo3tp9o99bov5d3255uvtm6d2